Kallo IncOver The Counter Market:KALO
- LAST PRICE0.0003
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0003
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Kallo Inc | 1.9M | -2.1x | --- |
InVivo Therapeutics Holdings Corp | 1.1M | -0.1x | --- |
SeqLL Inc | 536.7K | -0.1x | --- |
Quantrx Biomedical Corp | 314.8K | -1.2x | --- |
Biolife Sciences Inc | 3.2K | 0.0x | --- |
LifePoint Inc | 100.0 | 0.0x | --- |
Company Information
Kallo Inc. offers a healthcare delivery program. Its healthcare delivery program provides advanced healthcare solution that is customized to each country including infectious disease management and customized education and training programs. The Company’s technology suite transforms healthcare delivery through rural healthcare, disease management, clinical globalization, and e-health solutions. Its telehealth program is a technology connected to its global network of physicians, nurse practitioners, pharmacists, specialists, and surgeons specialized in minimal invasive procedures on a federated model. The telehealth program facilitates synchronous and asynchronous interactions where patients and staff are in different locations. Its maintenance services program includes three components: Biomedical Engineering services, Mechanical and Electrical Engineering services, and Information and Communications Technology.
Contact Information
- Headquarters
- 255 Duncan mill Road, Suit 504NORTH YORK, ON, Canada M3B3H9
- Phone
- 416-246-9997
- Fax
- 866-280-5239
Executives
- Chairman of the Board, President, Chief Executive Officer, Chief Financial Officer
- John Cecil
- Chief Operating Officer, Director
- Lloyd Chiotti
- Secretary, Director
- Samuel Baker
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.9M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 6.4B |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $0.00 |
Book Value | $0.00 |
P/E Ratio | -2.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
